Clinical Trials Logo

Paraplegia clinical trials

View clinical trials related to Paraplegia.

Filter by:

NCT ID: NCT04064385 Recruiting - Tetraplegia Clinical Trials

Functional Electrical Stimulation Cycling in SCI

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Spinal cord injury (SCI) is a devastating, life-altering injury; requiring tremendous changes in an individual's lifestyle. Cycling, provides an ideal way for individuals with SCI to exercise and address the long-term consequences of SCI by targeting the lower extremity muscles. Cycling with the addition of functional electrical stimulation (FES) allows persons with paralysis to exercise their paretic or paralysed leg muscles. The Queen Elizabeth National Spinal Injury Unit (QENSIU) in Glasgow offers FES cycling for people with spinal cord injuries, which combines functional electrical stimulation (FES) with a motorised ergometer that allows repetitive cycling activity. It stimulates muscles with electrodes attached to the skin, producing muscle contractions and patterned activity. So far no previous randomised control trials on FES cycling in the acute SCI population have reported changes in ability to undertake activities of daily living or the trunk balance.

NCT ID: NCT04055610 Recruiting - Clinical trials for Spinal Cord Injuries

Gait Training for Individuals With Paraplegia Using the H-MEX Exoskeleton

Start date: August 8, 2019
Phase: N/A
Study type: Interventional

This study evaluates the feasibility and effects of H-MEX powered exoskeleton in individuals with paraplegia as a result of spinal cord injury.

NCT ID: NCT04011137 Completed - Paraplegia Clinical Trials

High-intensity Interval Training and Mixed Meal Responses in Persons With Spinal Cord Injury

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

Persons with chronic paraplegia at an increased risk of developing cardiovascular disease and type-2 diabetes compared to the able-bodied population. There is mounting evidence from the able-bodied literature that high-intensity interval training (HIIT) is more effective than moderate-intensity continuous training (MICT) at improving markers of cardiometabolic health. Before we can understand the long-term training effects of HIIT in this population, it is important to compare the acute metabolic responses to a typical mixed-macronutrient meal following both exercise modalities. This study is recruiting adults (aged 18-65 years) with paraplegia (T2 or below) who sustained their spinal cord injury more than one-year ago. Participants will need to attend the laboratory at the University of Bath on four separate occasions, once for preliminary testing, and three times for study trials.

NCT ID: NCT04006418 Recruiting - Spastic Paraplegia Clinical Trials

A Registered Cohort Study on Spastic Paraplegia

Start date: July 1, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias(HSP) and related disorders in a prospective multicenter natural history study, to assess the clinical, genetic and epigenetic features of patients with Spastic Paraplegias to optimize clinicalmanagement..

NCT ID: NCT03992690 Recruiting - Chronic Paraplegia Clinical Trials

Training With Brain-machine Interfaces, Visuo-tactile Feedback and Assisted Locomotion for Patients With Chronic Complete Paraplegia

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this research is to compare the effectiveness of a training protocol integrating Brain-machine Interfaces, Visuo-tactile feedback and Assisted Locomotion (referred to as the Walk Again Neurorehabilitation protocol, or WANR), with classical physiotherapy training for patients with chronic complete paraplegia due to spinal cord injury.

NCT ID: NCT03981276 Recruiting - Clinical trials for Hereditary Spastic Paraplegia

Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

HSP-PBP
Start date: October 14, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias (HSP) and related disorders in a prospective multicenter natural history study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the genetic etiology and molecular mechanisms of these diseases.

NCT ID: NCT03961906 Completed - Clinical trials for Hereditary Spastic Paraplegia

Physiotherapy in Hereditary Spastic Paraplegia

Start date: January 1, 2015
Phase: Phase 2
Study type: Interventional

Goal of this study is to develop and evaluate a physiotherapy concept that is focused on bilateral leg spasticity and aims to reduce spastic gait disturbance and to improve mobility in patients suffering from HSP.

NCT ID: NCT03949699 Completed - Clinical trials for Spinal Cord Injuries

Resistance Training to Improve Strength and Functional Trunk Stability in Adults With Paraplegia

Start date: November 24, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of an 8- week resistance training routine to improve functional trunk strength, muscle activation, and physical functioning in exercise in 30 adults with paraplegic SCI. This study will also examine outcomes of confidence in one's ability to avoid falling during balance challenges, and self-efficacy for participating in exercise activity.

NCT ID: NCT03945331 Terminated - Paraplegia, Spinal Clinical Trials

Transcutaneous and Epidural Spinal Stimulation for Enabling Motor Function in Humans With Motor Complete Paraplegia

TransEpi
Start date: January 22, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to compare transcutaneous electrical spinal stimulation (TESS) and epidural electrical stimulation (EES); in particular, the motor activity enabled by each method and the potential health benefits of each method.

NCT ID: NCT03935724 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Stem Cells in Spinal Cord Injury

SCI2
Start date: January 18, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled and delayed-start phase II/III clinical study.